XP Inc. XP · NASDAQ
$30.41 +3.61% (+$1.06)
Summary
71 / 100 · Bulios Score
What speaks for it
- Out of every 100 BRL of revenue, 28 BRL is left as net profit.
- Earnings per share grew by 16% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- Analysts expect revenue to grow by 14% this fiscal year.
What to watch
- It cut its dividend by 72% last year.
- It missed profit estimates 4 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 14.4 BRL for 1 BRL of yearly profit. Over the last five years it was 14.5 BRL on average.
Valuation in detailIs it growing?
Yes, fastRevenue (BRL)
Diluted EPS (BRL)
- Analyst estimate
Revenue grew by 16% a year over 5 years. Over the last 3 years it grew by 8.8% a year. For the next fiscal year analysts expect revenue to grow by 14%. Earnings per share grew by 16% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 BRL of revenue goes
- Cost of sales 33 BRL
- Sales and administration 35 BRL
- Taxes and other 4.2 BRL
- Net profit 28 BRL
Net profit, industry median (Financial - Capital Markets) 20 BRL
Out of every 100 BRL of revenue, 28 BRL is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.29%
- Paid out of profit
- 19%
You receive $0.38 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 8
- Hold 2
- Sell 0
Today's price within the analysts' price targets
The average target of $24.57 is 19% below today's price. 80% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2024By product
The company reports no revenue by product.
By region
- BRAZIL 96%
- UNITED STATES 4.0%
- Europe 0.3%
BRAZIL brings in 96% of revenue. UNITED STATES grew fastest, by 27% a year.
Segments in detail